1. Home
  2. PMI vs ANIK Comparison

PMI vs ANIK Comparison

Compare PMI & ANIK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

PMI

Picard Medical Inc.

N/A

Current Price

$0.72

Market Cap

202.7M

Sector

N/A

ML Signal

N/A

Logo Anika Therapeutics Inc.

ANIK

Anika Therapeutics Inc.

HOLD

Current Price

$15.72

Market Cap

191.4M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PMI
ANIK
Founded
1981
1983
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Sector
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
202.7M
191.4M
IPO Year
N/A
1996

Fundamental Metrics

Financial Performance
Metric
PMI
ANIK
Price
$0.72
$15.72
Analyst Decision
Buy
Analyst Count
0
1
Target Price
N/A
$17.00
AVG Volume (30 Days)
128.1K
104.0K
Earning Date
03-25-2026
04-29-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
80.16
EPS
N/A
N/A
Revenue
N/A
$112,819,000.00
Revenue This Year
N/A
$5.98
Revenue Next Year
N/A
$7.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.81
$7.90
52 Week High
$13.68
$16.24

Technical Indicators

Market Signals
Indicator
PMI
ANIK
Relative Strength Index (RSI) 27.72 62.31
Support Level N/A $13.81
Resistance Level $1.37 $16.24
Average True Range (ATR) 0.06 0.56
MACD -0.01 -0.05
Stochastic Oscillator 4.52 75.29

Price Performance

Historical Comparison
PMI
ANIK

About PMI Picard Medical Inc.

Picard Medical Inc operates through its wholly owned subsidiary, a medical technology company focused on developing, manufacturing, and commercializing an implantable Total Artificial Heart. It is engaged in designing, manufacturing, producing, supplying, marketing, and selling medical device products, including TAH. The TAH is an implantable system designed to assume the full function of a failed human heart in patients suffering from advanced heart failure.

About ANIK Anika Therapeutics Inc.

Anika Therapeutics Inc operates in the OA Pain Management and regenerative solutions space, focusing on early intervention orthopedics. The company leverages proprietary hyaluronic acid (HA) technology to develop differentiated products and provides products and services. Its OA Pain Management products include Orthovisc, Monovisc, and Cingal. Monovisc and Orthovisc are single- and multi-injection HA viscosupplement products indicated for pain relief from OA conditions and are generally administered to patients in an office setting. In the United States, Monovisc and Orthovisc are marketed exclusively by Johnson & Johnson MedTech. It generates maximum revenue from the OEM Channel and derives the majority of its revenue from the United States, with a presence in Europe and other countries.

Share on Social Networks: